Restoration of dendritic cell homeostasis and Type I/Type III interferon levels in convalescent COVID-19 individuals

被引:10
|
作者
Rajamanickam, Anuradha [1 ]
Kumar, Nathella Pavan [2 ]
Pandiaraj, Arul Nancy [1 ]
Selvaraj, Nandhini [1 ]
Munisankar, Saravanan [1 ]
Renji, Rachel Mariam [1 ]
Venkatramani, Vijayalakshmi [1 ]
Murhekar, Manoj [3 ]
Thangaraj, Jeromie Wesley Vivian [3 ]
Kumar, Muthusamy Santhosh [3 ]
Kumar, Chethrapilly Purushothaman Girish [3 ]
Bhatnagar, Tarun [3 ]
Ponnaiah, Manickam [3 ]
Sabarinathan, Ramasamy [3 ]
Saravanakumar, Velusamy [3 ]
Babu, Subash [1 ]
机构
[1] ICER ICMR NIRT Int Ctr Excellence Res, Chennai, Tamil Nadu, India
[2] Immunol ICMR Natl Inst Res TB, Chennai, Tamil Nadu, India
[3] ICMR Natl Inst Epidemiol, Chennai, Tamil Nadu, India
关键词
Dendritic cell subsets; pDC; mDC; Type I IFNs; Type III IFNs; COVID-19; Acute and convalescent COVID-19; INFECTION;
D O I
10.1186/s12865-022-00526-z
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Plasmacytoid and myeloid dendritic cells play a vital role in the protection against viral infections. In COVID-19, there is an impairment of dendritic cell (DC) function and interferon secretion which has been correlated with disease severity. Results In this study, we described the frequency of DC subsets and the plasma levels of Type I (IFN alpha, IFN beta) and Type III Interferons (IFN lambda 1), IFN lambda 2) and IFN lambda 3) in seven groups of COVID-19 individuals, classified based on days since RT-PCR confirmation of SARS-CoV2 infection. Our data shows that the frequencies of pDC and mDC increase from Days 15-30 to Days 61-90 and plateau thereafter. Similarly, the levels of IFN alpha, IFN beta, IFN lambda 1, IFN lambda 2 and IFN lambda 3 increase from Days 15-30 to Days 61-90 and plateau thereafter. COVID-19 patients with severe disease exhibit diminished frequencies of pDC and mDC and decreased levels of IFN alpha, IFN beta, IFN lambda 1, IFN lambda 2 and IFN lambda 3. Finally, the percentages of DC subsets positively correlated with the levels of Type I and Type III IFNs. Conclusion Thus, our study provides evidence of restoration of homeostatic levels in DC subset frequencies and circulating levels of Type I and Type III IFNs in convalescent COVID-19 individuals.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Restoration of dendritic cell homeostasis and Type I/Type III interferon levels in convalescent COVID-19 individuals
    Anuradha Rajamanickam
    Nathella Pavan Kumar
    Arul Nancy Pandiaraj
    Nandhini Selvaraj
    Saravanan Munisankar
    Rachel Mariam Renji
    Vijayalakshmi Venkatramani
    Manoj Murhekar
    Jeromie Wesley Vivian Thangaraj
    Muthusamy Santhosh Kumar
    Chethrapilly Purushothaman Girish Kumar
    Tarun Bhatnagar
    Manickam Ponnaiah
    Ramasamy Sabarinathan
    Velusamy Saravanakumar
    Subash Babu
    BMC Immunology, 23
  • [2] Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection
    Severa, Martina
    Diotti, Roberta A.
    Etna, Marilena P.
    Rizzo, Fabiana
    Fiore, Stefano
    Ricci, Daniela
    Iannetta, Marco
    Sinigaglia, Alessandro
    Lodi, Alessandra
    Mancini, Nicasio
    Criscuolo, Elena
    Clementi, Massimo
    Andreoni, Massimo
    Balducci, Stefano
    Barzon, Luisa
    Stefanelli, Paola
    Clementi, Nicola
    Coccia, Eliana M.
    PLOS PATHOGENS, 2021, 17 (09)
  • [3] Dysregulation of type I interferon responses in COVID-19
    Dhiraj Acharya
    GuanQun Liu
    Michaela U. Gack
    Nature Reviews Immunology, 2020, 20 : 397 - 398
  • [4] The role of type I interferon in the treatment of COVID-19
    Sodeifian, Fatemeh
    Nikfarjam, Mahsa
    Kian, Naghmeh
    Mohamed, Kawthar
    Rezaei, Nima
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (01) : 63 - 81
  • [5] Dysregulation of type I interferon responses in COVID-19
    Acharya, Dhiraj
    Liu, GuanQun
    Gack, Michaela U.
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (07) : 397 - 398
  • [6] Serum levels of type I interferon (IFN-I) is associated with the severity of COVID-19
    Sun, Yuting
    Wang, Gang
    Wang, Rongshuai
    Ren, Liang
    Yuan, Zilin
    Liu, Yueping
    Wu, Yuzhang
    Chen, Rong
    Chen, Yongwen
    Diao, Bo
    JOURNAL OF MEDICAL MICROBIOLOGY, 2023, 72 (08)
  • [7] Type I interferon, anti-interferon antibodies, and COVID-19
    Calabrese, Leonard H.
    Winthrop, Kevin
    Strand, Vibeke
    Yazdany, Jinoos
    Walter, Jolan E.
    LANCET RHEUMATOLOGY, 2021, 3 (04): : E246 - E247
  • [8] Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individuals
    Mavragani, Clio P.
    Skarlis, Charalampos
    V. Kostopoulos, Ioannis
    Maratou, Eirini
    Moutsatsou, Paraskevi
    Terpos, Evangelos
    Tsitsilonis, Ourania E.
    Dimopoulos, Meletios-Athanasios
    Sfikakis, Petros P.
    CYTOKINE, 2022, 157
  • [9] Roles of Type I and III Interferons in COVID-19
    Choi, Hojun
    Shin, Eui-Cheol
    YONSEI MEDICAL JOURNAL, 2021, 62 (05) : 381 - 390
  • [10] The type I interferon response in COVID-19: implications for treatment
    Lee, Jeong Seok
    Shin, Eui-Cheol
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (10) : 585 - 586